GlassScriptPhysician profile
Ida K Fox
NPI 1629099031
$1,105.66
in general payments reported to CMS, 2019-2025
10 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.22 · 2020: $236 · 2023: $349 · 2024: $313 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $820.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $820.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $226.02 | 2020-2023 | Avance Nerve Graft |
| Rti Surgical, INC | $187.17 | 2024 | |
| Polynovo North America LLC | $158.47 | 2025 | Novosorb Btm |
| Sientra, INC. | $157.98 | 2020 | |
| Baxter Healthcare | $132.60 | 2023 | Biosurgery - Tisseel |
| Integra Lifesciences Corporation | $126.17 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Allergan, INC. | $49.22 | 2019 | |
| Abbvie INC. | $36.83 | 2023 | |
| Elite Orthopedics, LLC | $17.09 | 2023 | |
| Smith+Nephew, INC. | $14.11 | 2023 | Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ida Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.